View Archived ABS Webinar with Jack Zamora MD

Join Jack Zamora, M.D, for a 1-hour webinar as he discusses how he effectively uses syneron's Advanced Body Sculpting program to maximize patient results while increasing practice revenue.  Dr. Zamora will detail how he has successfully combined the minimally invasive LipoLite™ Laser LipoSculpture™ procedure with the non-invasive VelaShape™ treatments to achieve the optimal body sculpting effect.

See more in:

Expand Your Practice With Advanced Body Sculpting Procedures

Offer your patients greater satisfaction with Advanced Body Sculpting Procedures--by combining LipoLite laser assisted lipolysis with VelaShape post procedure treatments.  Great results can be seen in between 8 to 12 weeks.

As stand-alone aesthetic procedures, LipoLite and VelaShape have proven track records of success. 

As combination therapies, they are a flexible, innovative approach for offering your patients effective, minimally invasive treatments resulting in body contouring with smooth results and fast recovery.

 

See more in:

Khloe Kardashian Gets VelaShape

Syneron in Print >

Syneron Television Media Coverage

 

Khloe Kardashian Gets VelaShape
March 22, 2009

See more in:

Syneron manufactures and sells ablative and non-ablative medical aesthetic devices that use a wide variety of energies including Syneron's signature elos™ technology - the only combined energy platform (radio frequency and light energies) that effectively treats dermatological conditions including wrinkles, skin laxity, age spots, pigmentation, acne, rosacea, hair removal, leg veins, spider veins, and much more. The VelaShape™ and Lipolite™ devices provide safe & effective treatments for cellulite and circumferential reduction, and the newly introduced Matrix RF™ is the first RF-only, non-laser, non-light device that's FDA cleared for fractional resurfacing.  Syneron products are sold to dermatologists, plastic surgeons, family practitioners and other physicians, aestheticians, and medical spa professionals around the world.